IOBTQ
IO Biotech, Inc.
0.00 (0.00%)0.00USD30.6K成交股數7K市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 13.7M | 16.7M | 16.4M | 20.2M | 15.8M | 14.3M | 21.8M | 17.7M | 16.5M | 11.9M | 10.0M | 12.2M |
| 銷售管理費用 | 5.6M | 6.5M | 6.2M | 6.3M | 5.7M | 5.9M | 6.4M | 5.8M | 5.3M | 6.0M | 5.8M | 5.9M |
| 營業利益 | −19.4M-10% | −23.2M+15% | −22.6M-20% | −26.5M+13% | −21.5M-1% | −20.2M+13% | −28.2M+78% | −23.5M+29% | −21.9M | −17.9M | −15.9M | −18.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −8.4M-59% | −26.2M+35% | −22.4M-14% | −24.0M+11% | −20.7M-2% | −19.5M+14% | −26.2M+67% | −21.7M+17% | −21.2M | −17.0M | −15.7M | −18.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.13-58% | -0.40+33% | -0.34+55% | -0.36-16% | -0.31-58% | -0.30-49% | -0.22-59% | -0.43-33% | -0.74 | -0.59 | -0.54 | -0.64 |
| 稀釋股數 | 66.9M | 65.9M | 65.9M | 65.9M | 65.9M | 65.9M | 43.5M | 50.2M | 28.8M | 28.8M | 28.8M | 28.8M |
資產負債表 期末餘額
| 科目 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 30.7M | 28.1M | 37.1M | 80.2M | 101M | 118M | 143M | 166M | 110M | 129M | 151M | 170M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 40.0M | 42.3M | 45.7M | 89.9M | 111M | 128M | 151M | 173M | 118M | 137M | 162M | 183M |
| 有息負債 | 16.7M | 6.7M | 0 | – | – | – | – | – | – | – | – | – |
| 總負債 | 39.0M | 40.7M | 19.3M | 17.4M | 15.2M | 12.7M | 17.6M | 15.0M | 13.0M | 12.6M | 8.7M | 10.5M |
| 股東權益 | 911K | 1.6M | 26.4M | 72.6M | 96.3M | 115M | 133M | 158M | 105M | 124M | 153M | 172M |
| 負債比 | 97.7% | 96.2% | 42.2% | 19.3% | 13.6% | 9.9% | 11.6% | 8.7% | 11.1% | 9.2% | 5.3% | 5.7% |
| 淨現金(現金 − 有息負債) | 14.0M | 21.4M | 37.1M | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | −23.1M | – | – | −24.9M+70% | – | – | – | −14.7M | – | – |
| 資本支出 | – | – | 28K | – | – | 11K | – | – | – | 148K | – | – |
| 自由現金流 | – | – | −23.1M | – | – | −24.9M+68% | – | – | – | −14.8M | – | – |
| 折舊攤銷 | 100K | 100K | 100K | 100K | 100K | 100K | −50K | 100K | 100K | 50K | 10K | 0 |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2024 | – | – | −95.5M | –% | -1.45 | −82.4M |
| FY2023 | – | – | −86.1M | –% | -1.98 | −72.1M |
| FY2022 | – | – | −71.5M | –% | -2.48 | −60.4M |
| FY2021 | – | – | −67.9M | –% | -17.30 | −40.8M |
| FY2020 | – | – | −12.0M | –% | -82.36 | – |